Table 1.
LncRNAs regulate polarization types of Mφs and targets in cancers.
| LncRNAs | Polarization Types | Targets | Diseases | References |
|---|---|---|---|---|
| LncRNA ANCR | M1 | FOXO1 | Gastric cancer | (12) |
| LncRNA CCAT1 | M1 | MiR-148A | Colon cancer | (13). |
| LncRNA GAS5 | M1 | Unknown | Colorectal cancer | (14) |
| LncRNA LNMAT1 | M1 | CCL2 | Bladder cancer | (15) |
| LncRNA p21 | M1 | MDM2/p53/NF-κB/STAT3 | Breast cancer | (16) |
| LncRNA GNAS-AS1 | M2 | MiR-433-3p | Breast cancer | (17) |
| LncRNA BCRT1 | M2 | MiR-1303/PTBP3 | Breast cancer | (18) |
| LncRNA SNHG1 | M2 | STAT6 | Breast cancer | (19) |
| LncRNA 00337 | M2 | CD163/ARG1 | Breast cancer | (20) |
| LncRNA 00514 | M2 | Jagged1/Notch | Breast cancer | (21) |
| LncRNA GAS5 | M2 | PTEN | Hepatocellular carcinoma | (22) |
| LncRNA PART1 | M2 | MiR-372-3p/TLR4 | Hepatocellular carcinoma | (23) |
| LncRNA DLX6-AS1 | M2 | MiR-15a-5p/CXCL17 | Hepatocellular carcinoma | (24) |
| LncRNA TP73-AS1 | M2 | MiR-539/MMP-8/TGF-β1 | Hepatocellular carcinoma | (25) |
| LncRNA CRNDE | M2 | CD163 | Liver cancer | (26) |
| LncRNA HLA-F-AS1 | M2 | MiR-375/PFN1 | Colorectal cancer | (27) |
| LncRNA NBR2 | M2 | Arg-1/CD163/CD206 | Colorectal cancer | (28) |
| LncRNA PTTG3P | M2 | HIF1A | Colorectal cancer | (29) |
| LncRNA RPPH1 | M2 | TUBB3 | Colorectal cancer | (30) |
| LncRNA MIR155HG | M2 | MiR-650/ANXA2 | Colorectal cancer | (31) |
| LncRNA RP11-361F15.2 | M2 | MiR-30c-5p/CPEB4 | Osteosarcoma | (32) |
| LncRNA LOC100129620 | M2 | MiR-335-3p/CDK6 | Osteosarcoma | (33) |
| LncRNA NEAT1 | M2 | MiR-214/B7-H3 | Endometrial cancer | (34, 35) |
| LncRNA NIFK-AS1 | M2 | MiR-146a | Endometrial cancer | (36) |
| LncRNA-MM2P | M2 | STAT6 | Tumorigenesis | (37) |
| LncRNA CASC2c | M2 | FX | Brain tumor | (38) |
| LncRNA LINC01140 | M2 | MiR-140-5p/FGF9 | Bladder cancer | (39) |
| LncRNA GNAS-AS1 | M2 | MiR-4319/NECAB3 | Non-small cell lung cancer | (40) |
| LncRNA XIST | M2 | TCF-4 | Lung cancer | (41) |
| LncRNA DCST1-AS1 | M2 | NF-κB | Oral Squamous Cell Carcinoma | (42) |
| LncRNA FGD5-AS1 | M2 | MiR-129-5p/BST2 | Cervical cancer | (43) |
| LncRNA C00467 | M2 | MiR-494-3p/STAT3 | Prostate cancer | (44) |
| LncRNA HCG18 | M2 | MiR-875-3p/KLF4 | Gastric cancer | (45) |
| LncRNA TUC339 | M1/M2 | CXCR | Hepatocellular carcinoma | (46) |
| LncRNA COX-2 | M1/M2 | IL-12/iNOS/TNF-α/IL-10/Arg-1/Fizz-1 | Hepatocellular carcinoma | (47) |
| LncRNA Ma301 | M1/M2 | Caprin-1/Akt/Erk1 | Hepatocellular carcinoma | (48) |
| LncRNA LBX1-AS1 | Macrophage | MiR-182-5p/FOXO3 | Oral squamous cell carcinoma | (49) |
| LncRNA Xist | M1/M2 | MiR-101-3p/KLF6/C/EBPα | Breast cancer | (50) |
| LncRNA Xist | M1/M2 | MiR-101-3p/KLF6/C/EBPα | Ovarian tumor | (50) |